Conferees Set $1.991 Bil. NCI Budget, Ax Earmark For Breast Cancer, But Find $210 Mil. In Defense
In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award
Harkin Withdraws Amendment Allow NIH To Bypass INDS
Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited
NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program
Cancer Act Impact; Mortality Decline; DeVita Tells ACCC
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
